| Title : Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - Dubois_2023_Alzheimers.Res.Ther_15_39 |
| Author(s) : Dubois B , Lopez-Arrieta J , Lipschitz S , Triantafyllos D , Spiru L , Moroz S , Venger O , Vermersch P , Moussy A , Mansfield CD , Hermine O , Tsolaki M |
| Ref : Alzheimers Res Ther , 15 :39 , 2023 |
| Abstract : |
| PubMedSearch : Dubois_2023_Alzheimers.Res.Ther_15_39 |
| PubMedID: 36849969 |
| Title : Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial - Piette_2011_Alzheimers.Res.Ther_3_16 |
| Author(s) : Piette F , Belmin J , Vincent H , Schmidt N , Pariel S , Verny M , Marquis C , Mely J , Hugonot-Diener L , Kinet JP , Dubreuil P , Moussy A , Hermine O |
| Ref : Alzheimers Res Ther , 3 :16 , 2011 |
| Abstract : |
| PubMedSearch : Piette_2011_Alzheimers.Res.Ther_3_16 |
| PubMedID: 21504563 |